John Brancaccio
Chairman en HEPION PHARMACEUTICALS, INC. .
Fortuna: 24 579 $ al 30/04/2024
Origen de la red de primer grado John Brancaccio.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Medical Specialties | 53 | |
| Subsidiary | Pharmaceuticals: Major | 27 | |
| Public Company | Pharmaceuticals: Major | 23 | |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY.
12
| Extinct | Pharmaceuticals: Major | 12 |
| Public Company | Pharmaceuticals: Major | 12 | |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ.
11
| Private Company | Medical Specialties | 11 |
| Public Company | Biotechnology | 10 | |
| Public Company | Pharmaceuticals: Major | 8 | |
| Public Company | Pharmaceuticals: Major | 8 | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Accelerated Technologies, Inc.
 Accelerated Technologies, Inc. Medical DistributorsDistribution Services Accelerated Technologies, Inc. creates and accelerates cardiovascular medical devices. The company was founded by Martin B. Leon and Yuval Binur and is headquartered in Hackensack, NJ.
1
| Subsidiary | Medical Distributors | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a John Brancaccio a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Sales & Marketing Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
| University of Nebraska | College/University | Undergraduate Degree Corporate Officer/Principal | |
| SEQUENOM, INC. | Medical Specialties | Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Medical/Nursing Services | President Chief Tech/Sci/R&D Officer Chairman | |
| BIOCEPT, INC. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Chief Operating Officer | |
| BIODESIX, INC. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Pharmaceuticals: Other | Founder Director/Board Member Chief Tech/Sci/R&D Officer | |
| Brown University | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Graduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| Concordia University | College/University | Undergraduate Degree Graduate Degree | |
| Temple University (Pennsylvania) | College/University | Corporate Officer/Principal Masters Business Admin | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Alberta | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Nebraska Medical Center | College/University | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of the Sciences in Philadelphia | College/University | Corporate Officer/Principal Undergraduate Degree | |
Agendia NV
 Agendia NV Medical/Nursing ServicesHealth Services Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands. | Medical/Nursing Services | Sales & Marketing Corporate Officer/Principal | |
Helomics Corp.
 Helomics Corp. Medical/Nursing ServicesHealth Services Helomics Corp. provides cancer care development and treatment consulting services. Its products include chemoFx, biospeciFx, geneFx colon and geneFx lung. It also offers research and development services. The company was founded in 1995 and is headquartered in Pittsburgh, PA. | Medical/Nursing Services | Chief Executive Officer Sales & Marketing | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal President | |
| CHAMPIONS ONCOLOGY, INC. | Biotechnology | Founder Director of Finance/CFO Director/Board Member | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PREDICTIVE ONCOLOGY INC. | Medical Specialties | Chief Executive Officer Sales & Marketing | |
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ALLERGAN PLC | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Founder Chairman | |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Tiziana Life Sciences Ltd. engages in the development of therapies for neurodegenerative and lung diseases. Its clinical pipeline includes Foralumab, Anti IL-6R, and Milciclib. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member Chief Operating Officer Chief Operating Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer Director/Board Member | |
Arna Therapeutics Ltd.
 Arna Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Arna Therapeutics Ltd. is a British biotechnology company that focuses on research and experimental development. The private company was founded by Gabriele Marco Antonio Cerrone. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Gensignia Life Sciences, Inc. is a molecular diagnostics company that develops new molecular diagnosis techniques. The private company is based in San Diego, CA. The company was founded by Gabriele Marco Antonio Cerrone. | Biotechnology | Director/Board Member Founder Chief Tech/Sci/R&D Officer | |
| Smithkline Beecham Pharmaceuticals (Canada) | Corporate Officer/Principal Corporate Officer/Principal | ||
| New York University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 40 |
| Canadá | 7 |
| Reino Unido | 3 |
| Países Bajos | 2 |
| Irlanda | 2 |
Sectorial
| Health Technology | 26 |
| Consumer Services | 15 |
| Health Services | 6 |
| Commercial Services | 3 |
| Retail Trade | 2 |
Operativa
| Director/Board Member | 370 |
| Corporate Officer/Principal | 213 |
| Independent Dir/Board Member | 115 |
| Chief Executive Officer | 88 |
| Chairman | 85 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Tamar Howson | 41 |
| Paul Billings | 38 |
| Gary Pace | 32 |
| David Sidransky | 32 |
| James Sapirstein | 26 |
| Willy Simon | 24 |
| Thomas H. Adams | 22 |
| Gabriele Cerrone | 22 |
| Abba David Poliakoff | 21 |
| Stephen K. Carter | 20 |
| Alex Martin Martin | 19 |
| Riccardo Dalla-Favera | 18 |
| Richard Whitley | 18 |
| Rodney Markin | 18 |
| Christopher McGuigan | 17 |
- Bolsa de valores
- Insiders
- John Brancaccio
- Conexiones Empresas
